A longitudinal study of right ventricular function of patients with multiple myeloma treated with carfilzomib

A longitudinal study of right ventricular function of patients with multiple myeloma treated with carfilzomib

Saved in:

Bibliographic Details
Main Authors:	Sarah Basin, Mathilde Cezar, Antoine Fraix, Nathalie Pace, Laura Filippetti, Samantha Schulmann, Christine Selton-Suty, Olivier Huttin, François Chabot, Ari Chaouat, Simon Valentin
Format:	Article
Language:	English
Published:	European Respiratory Society 2025-03-01
Series:	ERJ Open Research
Online Access:	http://openres.ersjournals.com/content/11/2/00861-2024.full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Practical Aspects of the Use of Carfilzomib in Multiple Myeloma
by: SV Semochkin, et al.
Published: (2018-12-01)

Daratumumab plus carfilzomib: An optimistic approach in relapsed/refractory multiple myeloma
by: A P Dubey, et al.
Published: (2020-01-01)

Effective Management of Carfilzomib-Induced Thrombotic Microangiopathy in Multiple Myeloma Using Eculizumab
by: Jennifer Kim, et al.
Published: (2025-06-01)

Carfilzomib in multiple myeloma: unraveling cardiac toxicities - from mechanisms to diagnosis and management
by: Yi Gao, et al.
Published: (2025-03-01)

Pharmacoeconomic evaluation of carfilzomib versus ixazomib for the treatment of relapsed and refractory multiple myeloma
by: Lin Wang, et al.
Published: (2025-12-01)

Drug review: Carfilzomib
by: Prasanth Ganesan
Published: (2019-01-01)

MRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma
by: Manisha Bhutani, et al.
Published: (2025-02-01)

Tumor Lysis Syndrome with Venetoclax/Carfilzomib/Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Case Report
by: Reilly Fankhauser, et al.
Published: (2024-11-01)

Combined Proteasome and Autophagy Inhibition in Relapsed/Refractory Multiple Myeloma—A Phase I Trial of Hydroxychloroquine, Carfilzomib, and Dexamethasone
by: Tobias S. Slørdahl, et al.
Published: (2025-02-01)

Delayed Onset of Thrombotic Microangiopathy (TMA) upon Prolonged Carfilzomib Therapy in Multiple Myeloma: A Case Report and Comprehensive Review
by: Andrea Ceglédi, et al.
Published: (2024-12-01)

Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial.
by: Graham H Jackson, et al.
Published: (2021-01-01)

Histopathological and biochemical profiling of Carfilzomib-loaded Fe–Co MOFs
by: Mohammad Reza Hajinezhad, et al.
Published: (2025-08-01)

A Case of Carfilzomib-Induced Atypical Hemolytic Uremic Syndrome
by: Kwasi Opare-Addo, et al.
Published: (2024-06-01)

Using protein turnover assay to explore the drug mechanism of Carfilzomib
by: Tao Yonghui, et al.
Published: (2024-07-01)

Carfilzomib modulates tumor microenvironment to potentiate immune checkpoint therapy for cancer
by: Qian Zhou, et al.
Published: (2021-12-01)

Balancing the Risk of Cardiotoxicity Outcomes in Treatment Selection for Multiple Myeloma: A Retrospective Multicenter Evaluation of Ixazomib, Lenalidomide, and Dexamethasone (IRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (KRd)
by: Benjamin J. Lee, et al.
Published: (2025-06-01)

Identifying common pathways for doxorubicin and carfilzomib-induced cardiotoxicities: transcriptomic and epigenetic profiling
by: Conagh Kelly, et al.
Published: (2025-02-01)

Successful treatment with carfilzomib and dexamethasone for relapsed/refractory POEMS syndrome: a case report and review of literature
by: Shuang Yu, et al.
Published: (2025-06-01)

Effects of carfilzomib alone and in combination with cisplatin on the gene expression of Bcl-2 and Bax in ovarian carcinoma cell lines
by: Alireza Saedi, et al.
Published: (2025-03-01)

Carfilzomib promotes Iodine-125 seed radiation-induced apoptosis, paraptosis, and ferroptosis in esophageal squamous cell carcinoma by aggravating endoplasmic reticulum stress
by: Chao Wang, et al.
Published: (2025-07-01)

One CHiP to rule them all? Mechanistic insight into carfilzomib-induced lung injury with neutrophil extracellular trap formation following cellular immunotherapy
by: Julia Katharina Scholz, et al.
Published: (2025-02-01)

Correction: Sgherza et al. Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study. <i>Pharmaceuticals</i> 2025, <i>18</i>, 595
by: Nicola Sgherza, et al.
Published: (2025-06-01)

Turbulence modeling and simulation advances in CFD during the past 50 years
by: Schiestel, Roland, et al.
Published: (2022-10-01)

Aggressive FLC Escape in a Patient with IgD Myeloma
by: Cédric Farges, et al.
Published: (2015-01-01)

MANAJEMEN LATIHAN EKSTRAKURIKULER OLAHRAGA UNTUK MENINGKATKAN PRESTASI NON AKADEMIK SISWA (Studi Deskriptif Kualitatif di SDN Pasirhuni 01 Kecamatan Cimaung, Kabupaten Bandung)
by: Ricky Yoseptry, et al.
Published: (2025-08-01)

The Multiple Myeloma
by: Keivan Daneshvar, et al.
Published: (2024-03-01)

Atypical Presentation of Multiple Myeloma: From Heart Failure to Multiple Myeloma
by: Ainur Elliana Sohaimi, et al.
Published: (2024-10-01)

Archimandrite Tikhon (Bellavin) and hieromonk Antonin (Granovsky) in 1897
by: Semenenko-Basin Il'ia
Published: (2014-06-01)

Épiais-les-Louvres (Val-d’Oise), Mauregard et Mesnil-Amelot (Seine-et-Marne). Chemins modernes
by: Gaëlle Bruley-Chabot, et al.
Published: (2009-12-01)

Extramedullary CNS myeloma
by: Alessandro Gozzetti
Published: (2025-06-01)

Immunotherapy for Multiple Myeloma
by: Nicolaus Kröger, et al.
Published: (2012-01-01)

Insights into very elderly multiple myeloma treatment from Kansai Myeloma Forum
by: Yusuke Okayama, et al.
Published: (2025-12-01)

The Sec61 translocon is a therapeutic vulnerability in multiple myeloma
by: Antoine Domenger, et al.
Published: (2022-01-01)

Left Ventricular Diastolic Dysfunction in the Intensive Care Unit: Trends and Perspectives
by: Lewis Ari Eisen, et al.
Published: (2012-01-01)

Lenalidomide based triplets in relapsed/refractory multiple myeloma: analysis of the Czech Myeloma Group
by: Jiri Minarik, et al.
Published: (2025-04-01)

Pulmonary hypertension associated with COPD: a phenotype analysis
by: Mathilde Steger, et al.
Published: (2025-03-01)

Electrocardiographic Characteristics of Ventricular Arrhythmia Originating from the Left Coronary Cusp
by: Antoine Kossaify, et al.
Published: (2011-01-01)

The response of the Italian regions to the pandemic: a quanti-qualitative analysis
by: Andrea Filippetti, et al.
Published: (2023-12-01)

Metastatic Multiple Myeloma to the Skin
by: Alex C. Holliday, et al.
Published: (2019-01-01)

Laryngeal Involvement of Multiple Myeloma
by: Ariel B. Grobman, et al.
Published: (2012-01-01)